Free Trial

Cardiol Therapeutics (CRDL) Competitors

Cardiol Therapeutics logo
C$1.51 -0.08 (-5.03%)
As of 04/30/2025 04:00 PM Eastern

CRDL vs. TLRY, VBV, CUS, AIM, IPA, FRX, APM, GXE, ITH, and GPH

Should you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Tilray Brands (TLRY), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), Aimia (AIM), ImmunoPrecise Antibodies (IPA), Fennec Pharmaceuticals (FRX), Andean Precious Metals (APM), Gear Energy (GXE), International Tower Hill Mines (ITH), and Graphite One (GPH). These companies are all part of the "pharmaceutical products" industry.

Cardiol Therapeutics vs.

Cardiol Therapeutics (TSE:CRDL) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, institutional ownership, community ranking, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

In the previous week, Tilray Brands had 3 more articles in the media than Cardiol Therapeutics. MarketBeat recorded 3 mentions for Tilray Brands and 0 mentions for Cardiol Therapeutics. Tilray Brands' average media sentiment score of 1.02 beat Cardiol Therapeutics' score of 0.00 indicating that Tilray Brands is being referred to more favorably in the news media.

Company Overall Sentiment
Cardiol Therapeutics Neutral
Tilray Brands Positive

Cardiol Therapeutics has a net margin of 0.00% compared to Tilray Brands' net margin of -30.02%. Tilray Brands' return on equity of -7.24% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Cardiol TherapeuticsN/A -195.07% -54.15%
Tilray Brands -30.02%-7.24%-1.41%

Cardiol Therapeutics has higher earnings, but lower revenue than Tilray Brands. Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.51-2.97
Tilray BrandsC$610.34M0.72-C$183.24M-C$0.41-1.64

Cardiol Therapeutics received 9 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 69.23% of users gave Cardiol Therapeutics an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.

CompanyUnderperformOutperform
Cardiol TherapeuticsOutperform Votes
9
69.23%
Underperform Votes
4
30.77%
Tilray BrandsOutperform Votes
No Votes
Underperform Votes
7
100.00%

Cardiol Therapeutics has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 2.19, suggesting that its share price is 119% more volatile than the S&P 500.

11.4% of Cardiol Therapeutics shares are held by institutional investors. Comparatively, 11.2% of Tilray Brands shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by company insiders. Comparatively, 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Tilray Brands beats Cardiol Therapeutics on 8 of the 14 factors compared between the two stocks.

Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRDL vs. The Competition

MetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$125.30MC$2.21BC$5.57BC$5.65B
Dividend YieldN/A2.92%5.11%6.84%
P/E Ratio-2.973.9022.4429.27
Price / SalesN/A527.72394.09568.85
Price / Cash0.9810.2538.1883.07
Price / Book10.116.686.773.72
Net Income-C$42.93MC$20.70BC$3.22BC$300.39M
7 Day Performance0.67%1.21%1.49%0.29%
1 Month Performance12.69%2.49%4.00%-0.19%
1 Year Performance-46.83%92.60%16.21%14.06%

Cardiol Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRDL
Cardiol Therapeutics
N/AC$1.51
-5.0%
N/A-45.7%C$125.30MN/A-2.9720News Coverage
Gap Up
TLRY
Tilray Brands
N/AC$0.64
+4.9%
N/A-80.1%C$412.40MC$610.34M-1.552,650Positive News
VBV
VBI Vaccines
N/AN/AN/AN/AC$308.86MC$3.36M-4.9722
CUS
Chemtrade Electrochem Inc,
N/AN/AN/AN/AC$306.50MN/A0.0060
AIM
Aimia
1.8471 of 5 stars
C$2.46
-0.8%
C$4.00
+62.6%
+10.2%C$236.59MC$464.71M-3.0320News Coverage
Gap Up
IPA
ImmunoPrecise Antibodies
N/AC$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3080Gap Down
FRX
Fennec Pharmaceuticals
N/AC$7.08
flat
N/AN/AC$136.54MC$34.86M-119.9310
APM
Andean Precious Metals
2.9331 of 5 stars
C$1.29
+7.5%
C$2.00
+55.0%
N/AC$135.47MC$154.78M2.5530
GXE
Gear Energy
N/AN/AN/AN/AC$126.52MC$134.93M10.391,310
ITH
International Tower Hill Mines
N/AC$0.87
+2.4%
N/A+6.0%C$122.15MN/A-36.35220
GPH
Graphite One
N/AC$0.94
-1.1%
N/A+21.7%C$95.18MN/A-13.5220News Coverage

Related Companies and Tools


This page (TSE:CRDL) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners